SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-21-000015
Filing Date
2021-05-04
Accepted
2021-05-04 16:05:07
Documents
14
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ptct-20210504x8k.htm   iXBRL 8-K 45221
2 EX-99.1 ptct-20210504ex9919ca02a.htm EX-99.1 211778
3 GRAPHIC ptct-20210504ex9919ca02a001.jpg GRAPHIC 4125
  Complete submission text file 0001070081-21-000015.txt   398336

Data Files

Seq Description Document Type Size
4 EX-101.SCH ptct-20210504.xsd EX-101.SCH 3026
5 EX-101.LAB ptct-20210504_lab.xml EX-101.LAB 15408
6 EX-101.PRE ptct-20210504_pre.xml EX-101.PRE 9800
7 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20210504x8k_htm.xml XML 4636
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 21888350
SIC: 2834 Pharmaceutical Preparations